Medicis Sues Aurobindo Over U.S. Patents for Solodyn Acne Drug

Medicis Pharmaceutical Corp. sued Indian rival Aurobindo Pharma Ltd. in federal court in Delaware, seeking to block a generic form of the acne medicine Solodyn and alleging infringement of two U.S. patents.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE